Home/Filings/4/0001683168-18-002939
4//SEC Filing

Garnette Sophia 4

Accession 0001683168-18-002939

CIK 0001355790other

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 4:45 PM ET

Size

8.7 KB

Accession

0001683168-18-002939

Insider Transaction Report

Form 4
Period: 2018-10-02
Bakalova Sofya
Dir. of Legal Affairs & Oper.
Transactions
  • Sale

    Common Stock

    2018-10-02$1.58/sh1,494$2,361267 total
  • Exercise/Conversion

    Common Stock

    2018-10-02$1.10/sh+1,494$1,6431,761 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2018-10-021,49447,858 total
    Exercise: $1.10Exp: 2027-05-31Common Stock (49,352 underlying)
Footnotes (2)
  • [F1]The reported shares were sold in open market transactions through a broker-dealer at $1.58 per share.
  • [F2]The option, representing a total of 60,000 shares, became exercisable "vested" in installments. 3/36th of the shares underlying such options vested on August 31, 2017, and the remaining shares in equal monthly installments over a period of 33 months.

Documents

1 file

Issuer

International Stem Cell CORP

CIK 0001355790

Entity typeother

Related Parties

1
  • filerCIK 0001616590

Filing Metadata

Form type
4
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:45 PM ET
Size
8.7 KB